FDA Cites Optikem for Unsanitary Conditions, Lack of Records

Drug GMP Report
A A
The FDA hit Optikem with a Form 483 after the agency’s investigator observed unsanitary conditions and problems with records in an inspection of the firm’s Denver facility.

To View This Article:

Login

Subscribe To Drug GMP Report